Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/publication-of-data-from-wil-31-study-marks-a-milestone-in-improving-long-term-care-for-patients-with-severe-von-willebrand-disease-vwd-302040575.html
https://www.prnewswire.com/news-releases/octapharma-to-present-clinical-and-scientific-data-that-advances-our-understanding-and-treatment-of-bleeding-disorders-at-the-17th-annual-congress-of-the-european-association-for-haemophilia-and-allied-disorders-eahad-which-tak-302037036.html
https://www.prnewswire.com/news-releases/octapharma-announces-availability-of-balfaxar-for-warfarin-reversal-in-urgent-surgery--invasive-procedures-302024672.html
https://www.prnewswire.com/news-releases/octapharma-usa-fda-grants-expanded-approval-to-wilate-as-the-first-vwf-concentrate-for-prophylaxis-in-all-types-of-vwd-302005285.html
https://www.prnewswire.com/news-releases/octapharma-ag-indirect-comparison-data-indicate-that-personalised-prophylaxis-with-nuwiq-may-lead-to-fewer-patients-with-haemophilia-a-having-bleeds-than-with-other-recombinant-factor-viii-products-301972710.html
https://www.fiercepharma.com/pharma/octapharma-secures-fda-nod-coagulant-balfaxar-answer-blood-thinner-warfarin
https://www.prnewswire.com/news-releases/octapharma-presents-new-data-at-isth-2023-in-an-ongoing-commitment-to-improve-the-lives-of-people-with-bleeding-disorders-301843297.html
https://www.prnewswire.com/news-releases/octapharma-presents-new-data-at-isth-2023-in-an-ongoing-commitment-to-improve-the-lives-of-people-with-bleeding-disorders-301842617.html
https://www.prnewswire.com/news-releases/octapharma-usa-requests-fda-approval-for-wilate-vwd-prophylaxis-supplement-301753532.html